Literature DB >> 19775773

Noroviruses in healthcare settings: a challenging problem.

M Koopmans1.   

Abstract

Current knowledge about noroviruses in relation to healthcare-associated infections (HCAIs) merely scratches the surface. Most data come from outbreak-based studies, which represent only a small piece of the puzzle. Nevertheless, the data available show that the clinical impact of noroviruses is particularly severe in outbreaks in healthcare settings, and that it may be increasing. Coupled with the projected increases of the population aged >65 years, especially those needing healthcare, it is timely to consider noroviruses in discussions around HCAIs. In particular, broadening the scope from a field mostly discussing bacteriological problems and a more holistic approach to dealing with HCAIs may be needed to avoid introducing new risks when trying to deal with the antimicrobial resistance problem.

Mesh:

Year:  2009        PMID: 19775773     DOI: 10.1016/j.jhin.2009.06.028

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  16 in total

1.  [Nosocomial diarrhea].

Authors:  S Weis; M Grimm
Journal:  Internist (Berl)       Date:  2011-02       Impact factor: 0.743

2.  Year-round prevalence of norovirus in the environment of catering companies without a recently reported outbreak of gastroenteritis.

Authors:  Ingeborg L A Boxman; Linda Verhoef; Remco Dijkman; Geke Hägele; Nathalie A J M Te Loeke; Marion Koopmans
Journal:  Appl Environ Microbiol       Date:  2011-03-04       Impact factor: 4.792

3.  Inactivation Kinetics and Mechanism of a Human Norovirus Surrogate on Stainless Steel Coupons via Chlorine Dioxide Gas.

Authors:  Jia Wei Yeap; Simran Kaur; Fangfei Lou; Erin DiCaprio; Mark Morgan; Richard Linton; Jianrong Li
Journal:  Appl Environ Microbiol       Date:  2015-10-16       Impact factor: 4.792

Review 4.  A review of known and hypothetical transmission routes for noroviruses.

Authors:  Elisabeth Mathijs; Ambroos Stals; Leen Baert; Nadine Botteldoorn; Sarah Denayer; Axel Mauroy; Alexandra Scipioni; Georges Daube; Katelijne Dierick; Lieve Herman; Els Van Coillie; Mieke Uyttendaele; Etienne Thiry
Journal:  Food Environ Virol       Date:  2012-11-03       Impact factor: 2.778

5.  Unrecognized norovirus infections in health care institutions and their clinical impact.

Authors:  Matthias F C Beersma; Faizel H A Sukhrie; Jolanda Bogerman; Linda Verhoef; Mariana Mde Melo; Alieke G Vonk; Marion Koopmans
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

6.  Assessment of a rapid immunochromatographic test for the diagnosis of norovirus gastroenteritis.

Authors:  K Pombubpa; L Kittigul
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-23       Impact factor: 3.267

7.  Emergence of a new norovirus GII.4 variant and changes in the historical biennial pattern of norovirus outbreak activity in Alberta, Canada, from 2008 to 2013.

Authors:  Maria E Hasing; Bonita E Lee; Jutta K Preiksaitis; Raymond Tellier; Lance Honish; Ambikaipakan Senthilselvan; Xiaoli L Pang
Journal:  J Clin Microbiol       Date:  2013-05-01       Impact factor: 5.948

8.  A large common-source outbreak of norovirus gastroenteritis in a hotel in Singapore, 2012.

Authors:  P Raj; J Tay; L W Ang; W S Tien; M Thu; P Lee; Q Y Pang; Y L Tang; K Y Lee; S Maurer-Stroh; V Gunalan; J Cutter; K T Goh
Journal:  Epidemiol Infect       Date:  2016-10-28       Impact factor: 4.434

9.  In vivo comparison of two human norovirus surrogates for testing ethanol-based handrubs: the mouse chasing the cat!

Authors:  Syed A Sattar; Mohammad Ali; Jason A Tetro
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

10.  Novel norovirus recombinants and of GII.4 sub-lineages associated with outbreaks between 2006 and 2010 in Belgium.

Authors:  Elisabeth Mathijs; Sarah Denayer; Leonor Palmeira; Nadine Botteldoorn; Alexandra Scipioni; Alain Vanderplasschen; Etienne Thiry; Katelijne Dierick
Journal:  Virol J       Date:  2011-06-18       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.